New Promising Therapeutic Applications of Biosynthesis Nanomaterials: Outcome and Pathways

Dear Colleagues,

Nanobiotechnology is a novel concept and area of nanotechnology that has attracted worldwide interest. Green nanotechnology is the ideal approach to minimize the effects of nanomaterial manufacturing and application while also reducing the risks of problems associated with other methods. The eco-friendly mechanism and low toxicity of the applied and obtained compounds have already helped to radically increase the popularity of the biological synthesis method. In the context of medical use, this means, first of all, the absence of a toxic effect for humans, as well as a targeted effect. Due to their unique physicochemical properties, nanomaterials have received increased attention regarding their use in biological approaches and are capable of opening a new chapter in the treatment of various diseases. The different biological activities can make them indispensable assistants in the fight against diseases of the most diverse origin, such as antibacterial, antiviral, anticancer, anti-inflammatory, insecticidal agents, drug delivery, and other types of diagnostics and therapy. Studying the mechanisms of “biosynthesis” nanomaterials on living cells can not only bring us closer to solving a considerable number of modern medical problems but also expand the application horizons of these amazing objects.

In this Special Issue, we aim to publish studies on the current and potential applications of nanomaterials in biomedical research and practice, agriculture, bioremediation, and other areas, as well as synthesis mechanisms and interaction with living objects, which can become the basis of their potential multipolar application. Both original research papers and review articles are invited.

Dr. Muthu Thiruvengadam
Dr. Govindasamy Rajakumar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomaterials
• biosynthesis
• biomedical application
• nanoparticles
• outcome and pathways
• nanoformulations
• nanomedicine
• nanodrug delivery